XML 71 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash Flows from Operating Activities:    
Net income $ 102,789 $ 118,562
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 127,994 121,033
Amortization of financing costs 912 361
Amortization of net loss on treasury lock 1,574 (1,385)
Share-based compensation expense 8,477 7,191
Deferred income tax provision 31,445 21,377
Cellulosic biofuel producer credit reduction 142,251  
Alternative fuel mixture credits (72,436)  
Loss on disposals of property, plant and equipment 4,668 6,970
Loss on early extinguishment of debt 21,296  
Pension and postretirement benefits (7,775) 2,619
Other, net (3,354) (3,752)
Increase in assets -    
Accounts receivable (52,528) (39,374)
Inventories (4,217) (1,346)
Prepaid expenses and other current assets (8,587) (5,269)
Increase (decrease) in liabilities -    
Accounts payable (10,650) 22,474
Accrued liabilities (30,048) (12,644)
Net cash provided by operating activities 251,811 236,817
Cash Flows from Investing Activities:    
Additions to property, plant and equipment (94,396) (214,958)
Treasury grant proceeds 57,399  
Acquisitions of businesses (35,393) (35,643)
Additions to other long term assets (1,181) (10,973)
Proceeds from disposals of property, plant and equipment 25 427
Net cash used for investing activities (73,546) (261,147)
Cash Flows from Financing Activities:    
Proceeds from long-term debt 397,044  
Payments on long-term debt (433,202) (498)
Financing costs paid (821)  
Settlement of treasury lock (65,500) 9,910
Common stock dividends paid (68,776) (56,053)
Repurchases of common stock (41,524) (93,425)
Proceeds from exercise of stock options 16,121 6,870
Excess tax benefits from share-based awards 2,986 1,087
Net cash used for financing activities (193,672) (132,109)
Net decrease in cash and cash equivalents (15,407) (156,439)
Cash and cash equivalents, beginning of period 156,313 196,556
Cash and cash equivalents, end of period $ 140,906 $ 40,117